Market Research Logo

Global Attention-Deficit Hyperactivity Disorder (ADHD) Market: Size, Trends and Forecast (2019-2023)

Global Attention-Deficit Hyperactivity Disorder (ADHD) Market: Size, Trends and Forecast (2019-2023)

Scope of the Report

The report entitled “Global Attention-Deficit Hyperactivity Disorder (ADHD) Market: Size, Trends and Forecast (2019-2023)” provides an in-depth analysis of the ADHD market including detailed description of market sizing and growth. The report provides an analysis of the global ADHD market by value, by segments and by distribution channel. The report also provides regional analysis of the ADHD market for the following regions: North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall ADHD market has also been forecasted for the period 2019-2023, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The major players dominating the attention-deficit hyperactivity disorder (ADHD) market are Johnson & Johnson, Pfizer Inc., Eli Lilly and Company and Takeda Pharmaceutical Company Limited (Shire Plc). The four companies have been profiled in the report providing their business overview, financial overview and business strategies.

Country Coverage

North America
Europe
Asia-Pacific
Middle East and Africa
Latin America

Company Coverage

Johnson & Johnson
Pfizer Inc.
Eli Lilly and Company
Takeda Pharmaceutical Company Limited (Shire Plc)

Executive Summary

ADHD is a complex neurological disorder which creates difficulty for a person in paying attention and in controlling their behavior. The symptoms of ADHD might vary from person to person, but the most common symptoms include restlessness, difficulty in paying attention, hyperactivity, frequent mood swings and difficulty in coping with stress. A person diagnosed with ADHD can suffer from the hyperactive-type, inattentive type or the combined type attention deficit disorder.

The most common factors which cause the attention-deficit hyperactivity disorder in people include exposure to environmental toxins such as high levels of lead at a young age, low birth weight, genes, brain injuries, etc. ADHD can be treated with the use of medication, therapy, education and training or a combination of these treatments.

ADHD has been segmented on the basis of medication type, therapy, age group and distribution channel. The two major kinds of medication for the treatment of ADHD are stimulants and non-stimulants. Various kinds of therapies for ADHD include behavior therapy, cognitive behavioral therapy, interpersonal therapy and family therapy. On the basis of age group, ADHD has been segmented into pediatric, adolescent and adult and the major distribution channels for ADHD are retail pharmacy and hospital pharmacy.

The global attention-deficit hyperactivity disorder (ADHD) market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2019-2023). The market is expected to be driven by various growth enhancing factors such as rising healthcare expenditure, excessive use of smartphones, increasing investments in mental health technology, growing impact of social media, etc. Some of the major challenges faced by the market are misuse of drugs used in the treatment of ADHD and high cost of ADHD treatment.


1. Executive Summary
2. Introduction
2.1 Attention-Deficit Hyperactivity Disorder (ADHD): An Overview
2.1.1 Causes of ADHD
Table 1: Causes of ADHD
2.1.2 Symptoms of ADHD
Table 2: Symptoms of ADHD
2.1.3 ADHD Subtypes
Table 3: ADHD Subtypes
2.2 ADHD Treatment: An Overview
2.2.1 ADHD Treatment
Table 4: Drugs Used In Treatment of ADHD
2.3 ADHD Segmentation: An Overview
2.3.1 ADHD Segmentation by Medication Type
Table 5: ADHD Segmentation by Medication Type
2.3.2 ADHD Segmentation by Therapy
Table 6: ADHD Segmentation by Therapy
2.3.3 ADHD Segmentation by Age Group and Distribution Channel
Table 7: ADHD Segmentation by Age Group and Distribution Channel
3. Global Market Analysis
3.1 Global ADHD Market: An Analysis
3.1.1 Global ADHD Market by Value
Table 8: Global ADHD Market by Value; 2015-2018 (US$ Billion)
Table 9: Global ADHD Market by Value; 2019-2023 (US$ Billion)
3.1.2 Global ADHD Market by Region (North America, Europe, Asia Pacific, Middle East and Africa, Latin America)
Table 10: Global ADHD Market by Region; 2018 (Percentage, %)
3.1.3 Global ADHD Market by Segments (Stimulant, Non-Stimulant)
Table 11: Global ADHD Market by Segments; 2018 (Percentage, %)
3.1.4 Global ADHD Market by Distribution Channel (Retail Pharmacy, Hospital Pharmacy)
Table 12: Global ADHD Market by Distribution Channel; 2018 (Percentage, %)
3.2 Global ADHD Market: Segment Analysis
3.2.1 Global Stimulant ADHD Market by Value
Table 13: Global Stimulant ADHD Market by Value; 2015- 2018 (US$ Billion)
Table 14: Global Stimulant ADHD Market by Value; 2019- 2023 (US$ Billion)
3.2.2 Global Non-Stimulant ADHD Market by Value
Table 15: Global Non-Stimulant ADHD Market by Value; 2015- 2018 (US$ Billion)
Table 16: Global Non-Stimulant ADHD Market by Value; 2019-2023 (US$ Billion)
3.3 Global ADHD Market: Distribution Channel Analysis
3.3.1 Global Retail Pharmacy ADHD Market by Value
Table 17: Global Retail Pharmacy ADHD Market by Value; 2018-2023 (US$ Billion)
3.3.2 Global Hospital Pharmacy ADHD Market by Value
Table 18: Global Hospital Pharmacy ADHD Market by Value; 2018-2023 (US$ Billion)
4. Regional Market Analysis
4.1 North America ADHD Market: An Analysis
4.1.1 North America ADHD Market by Value
Table 19: North America ADHD Market by Value; 2015-2018 (US$ Billion)
Table 20: North America ADHD Market by Value; 2019-2023 (US$ Billion)
4.1.2 North America ADHD Market by Region (The US, North America (Excluding the US))
Table 21: North America ADHD Market by Region; 2018 (Percentage, %)
4.1.3 The US ADHD Market by Value
Table 22: The US ADHD Market by Value; 2015-2018 (US$ Billion)
Table 23: The US ADHD Market by Value; 2019-2023 (US$ Billion)
4.1.4 The US ADHD Market by Segments (Stimulant and Non-Stimulant)
Table 24: The US ADHD Market by Segments; 2018 (Percentage, %)
4.1.5 The US Stimulant ADHD Market by Value
Table 25: The US Stimulant ADHD Market by Value; 2015-2018 (US$ Billion)
Table 26: The US Stimulant ADHD Market by Value; 2019-2023 (US$ Billion)
4.1.6 The US Non-Stimulant ADHD Market by Value
Table 27: The US Non-Stimulant ADHD Market by Value; 2015-2018 (US$ Billion)
Table 28: The US Non-Stimulant ADHD Market by Value; 2019-2023 (US$ Billion)
4.1.7 North America (Excluding the US) ADHD Market by Value
Table 29: North America (Excluding the US) ADHD Market by Value; 2015-2018 (US$ Billion)
Table 30: North America (Excluding the US) ADHD Market by Value; 2019-2023 (US$ Billion)
4.2 Europe ADHD Market: An Analysis
4.2.1 Europe ADHD Market by Value
Table 31: Europe ADHD Market by Value; 2015-2018 (US$ Billion)
Table 32: Europe ADHD Market by Value; 2019-2023 (US$ Billion)
4.3 Asia-Pacific ADHD Market: An Analysis
4.3.1 Asia-Pacific ADHD Market by Value
Table 33: Asia-Pacific ADHD Market by Value; 2015-2018 (US$ Billion)
Table 34: Asia-Pacific ADHD Market by Value; 2019-2023 (US$ Billion)
4.4 Middle East and Africa ADHD Market: An Analysis
4.4.1 Middle East and Africa ADHD Market by Value
Table 35: Middle East and Africa ADHD Market by Value; 2015-2018 (US$ Billion)
Table 36: Middle East and Africa ADHD Market by Value; 2019-2023 (US$ Billion)
4.5 Latin America ADHD Market: An Analysis
4.5.1 Latin America ADHD Market by Value
Table 37: Latin America ADHD Market by Value; 2015-2018 (US$ Billion)
Table 38: Latin America ADHD Market by Value; 2019-2023 (US$ Billion)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Healthcare Expenditure
Table 39: Global Healthcare Expenditure; 2013-2018 (US$ Trillion)
5.1.2 Excessive Use of Smartphones
Table 40: Global Smartphone Users and Penetration; 2014-2020 (Billion, Percentage, %)
5.1.3 Increasing Investments in Mental Health Technology
Table 41: Global Venture Capital Funding in Mental Health Technology; 2013-2018 (US$ Million)
5.1.4 Growing Impact of Social Media
Table 42: Global Number of Social Media Users; 2014-2021 (Billion)
5.1.5 Increasing Mental Health Awareness
Table 43: The US Mental Healthcare Expenditure; 2013-2020 (US$ Billion)
5.1.6 Stressful Lifestyle
Table 44: Global Employment by Region; 2015-2018 (Million)
5.2 Challenges
5.2.1 Misuse of Drugs Used in the Treatment of ADHD
5.2.2 High Cost of ADHD Treatment
5.3 Market Trends
5.3.1 Growing Use of Combination Therapy
5.3.2 Rising Demand for Neurofeedback Therapy
5.3.3 Development of New Drugs
Table 45: ADHD Drugs in Development
6. Competitive Landscape
6.1 Global ADHD Market Players: Financial Comparison
Table 46: Global ADHD Market Players Financial Comparison; 2018
6.2 Global ADHD Market Players by Research and Development Expenditure
Table 47: Global ADHD Market Players by Research and Development Expenditure; 2016-2018 (US$ Billion)
7. Company Profiles
7.1 Johnson & Johnson
7.1.1 Business Overview
7.1.2 Financial Overview
Table 48: Johnson & Johnson Total Sales; 2014-2018 (US$ Billion)
Table 49: Johnson & Johnson Total Sales by Segments; 2018 (Percentage, %)
Table 50: Johnson & Johnson Total Sales by Region; 2018 (Percentage, %)
7.1.3 Business Strategy
7.2 Pfizer Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
Table 51: Pfizer Inc. Revenue; 2014-2018 (US$ Billion)
Table 52: Pfizer Inc. Revenue by Segments; 2018 (Percentage, %)
Table 53: Pfizer Inc. Revenue by Region; 2018 (Percentage, %)
7.2.3 Business Strategy
7.3 Eli Lilly and Company
7.3.1 Business Overview
7.3.2 Financial Overview
Table 54: Eli Lilly and Company Revenue; 2014-2018 (US$ Billion)
Table 55: Eli Lilly and Company Revenue by Segments; 2018 (Percentage, %)
Table 56: Eli Lilly and Company Revenue by Region; 2018 (Percentage, %)
7.3.3 Business Strategy
7.4 Takeda Pharmaceutical Company Limited (Shire Plc)
7.4.1 Business Overview
7.4.2 Financial Overview
Table 57: Takeda Pharmaceutical Company Limited Revenue; 2014-2018 (US$ Billion)
Table 58: Takeda Pharmaceutical Company Limited Revenue by Region; 2018 (Percentage, %)
7.4.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report